BioScience Health Innovations, Inc.
BHIC
$9.01
-$0.99-9.90%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 231.53% | 208.73% | 358.81% | 611.06% | 732.08% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 231.53% | 208.73% | 358.81% | 611.06% | 732.08% |
| Cost of Revenue | 445.04% | 373.92% | 546.98% | 845.18% | 957.34% |
| Gross Profit | 184.88% | 170.21% | 324.94% | 572.86% | 694.03% |
| SG&A Expenses | 51.57% | 66.04% | 125.21% | 152.85% | 248.27% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 106.81% | 107.04% | 163.15% | 189.93% | 284.37% |
| Operating Income | 342.19% | 134.59% | 116.45% | 71.51% | -30.98% |
| Income Before Tax | 342.19% | 134.59% | 113.18% | 76.69% | 1.18% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 342.19% | 134.59% | 113.18% | 76.69% | 1.18% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 342.19% | 134.59% | 113.18% | 76.69% | 1.18% |
| EBIT | 342.19% | 134.59% | 116.45% | 71.51% | -30.98% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 328.07% | 121.05% | 105.33% | 92.65% | 74.78% |
| Normalized Basic EPS | 325.00% | 120.00% | 104.72% | 92.16% | 74.47% |
| EPS Diluted | 264.56% | 117.09% | 92.31% | 83.67% | 65.04% |
| Normalized Diluted EPS | 322.22% | 120.00% | 104.72% | 92.16% | 74.47% |
| Average Basic Shares Outstanding | 4.85% | 24.38% | 60.00% | 125.67% | 283.98% |
| Average Diluted Shares Outstanding | 6.14% | 25.63% | 60.00% | 125.67% | 283.98% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |